Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Radiation Protection | 12 | 2022 | 426 | 4.070 |
Why?
|
Radiobiology | 14 | 2024 | 90 | 3.080 |
Why?
|
Bystander Effect | 13 | 2024 | 89 | 2.680 |
Why?
|
Dose-Response Relationship, Radiation | 19 | 2024 | 880 | 1.390 |
Why?
|
Health Physics | 4 | 2017 | 32 | 1.300 |
Why?
|
Radiation Dosage | 11 | 2024 | 1962 | 1.220 |
Why?
|
Chondrosarcoma | 2 | 2024 | 295 | 1.090 |
Why?
|
Fibroblasts | 12 | 2020 | 4138 | 1.060 |
Why?
|
DNA Repair | 13 | 2024 | 2041 | 1.020 |
Why?
|
Rad51 Recombinase | 5 | 2024 | 189 | 1.010 |
Why?
|
DNA Damage | 20 | 2024 | 2443 | 0.990 |
Why?
|
Dithiothreitol | 15 | 2000 | 93 | 0.960 |
Why?
|
Protons | 7 | 2020 | 1111 | 0.910 |
Why?
|
Radiation-Protective Agents | 15 | 2009 | 88 | 0.870 |
Why?
|
Radiation Tolerance | 14 | 2019 | 478 | 0.820 |
Why?
|
Sulfhydryl Compounds | 12 | 2000 | 296 | 0.780 |
Why?
|
Heavy Ions | 3 | 2019 | 11 | 0.750 |
Why?
|
Cell Survival | 22 | 2018 | 5778 | 0.680 |
Why?
|
Monte Carlo Method | 8 | 2022 | 1256 | 0.670 |
Why?
|
Radiotherapy | 3 | 2019 | 1500 | 0.620 |
Why?
|
Societies, Scientific | 2 | 2017 | 223 | 0.600 |
Why?
|
Hydrogen Peroxide | 11 | 2019 | 731 | 0.600 |
Why?
|
Glutathione | 14 | 2000 | 581 | 0.590 |
Why?
|
Radiometry | 5 | 2024 | 812 | 0.570 |
Why?
|
Radiation Injuries | 4 | 2020 | 1191 | 0.570 |
Why?
|
DNA Breaks, Double-Stranded | 7 | 2020 | 613 | 0.560 |
Why?
|
Iron | 5 | 2012 | 1791 | 0.550 |
Why?
|
United States National Aeronautics and Space Administration | 1 | 2016 | 15 | 0.540 |
Why?
|
X-Rays | 9 | 2019 | 307 | 0.520 |
Why?
|
Nuclear Medicine | 1 | 2019 | 257 | 0.500 |
Why?
|
Radiation Oncology | 3 | 2019 | 563 | 0.480 |
Why?
|
Radiation-Sensitizing Agents | 7 | 2018 | 349 | 0.470 |
Why?
|
Relative Biological Effectiveness | 6 | 2019 | 311 | 0.460 |
Why?
|
Elementary Particles | 1 | 2012 | 52 | 0.420 |
Why?
|
Laboratories | 1 | 2016 | 462 | 0.410 |
Why?
|
Epidemiologic Studies | 1 | 2016 | 677 | 0.400 |
Why?
|
Radiography | 2 | 2019 | 6974 | 0.370 |
Why?
|
Linear Energy Transfer | 7 | 2020 | 151 | 0.360 |
Why?
|
Drug Tolerance | 1 | 2012 | 367 | 0.350 |
Why?
|
Guidelines as Topic | 1 | 2017 | 1385 | 0.350 |
Why?
|
Film Dosimetry | 1 | 2020 | 29 | 0.340 |
Why?
|
Ions | 1 | 2010 | 255 | 0.340 |
Why?
|
Space Flight | 1 | 2012 | 216 | 0.340 |
Why?
|
Neoplasms | 11 | 2024 | 22142 | 0.340 |
Why?
|
Radiotherapy Dosage | 4 | 2024 | 2897 | 0.330 |
Why?
|
Extraterrestrial Environment | 1 | 2009 | 25 | 0.330 |
Why?
|
Health Services Needs and Demand | 1 | 2017 | 1401 | 0.320 |
Why?
|
Apoptosis | 14 | 2019 | 9478 | 0.300 |
Why?
|
Cells | 2 | 2009 | 164 | 0.300 |
Why?
|
Weightlessness Simulation | 2 | 2018 | 41 | 0.300 |
Why?
|
Iron Isotopes | 1 | 2007 | 19 | 0.300 |
Why?
|
Micronucleus Tests | 3 | 2012 | 23 | 0.290 |
Why?
|
Signal Transduction | 10 | 2024 | 23419 | 0.290 |
Why?
|
Oxygen | 17 | 2019 | 4228 | 0.280 |
Why?
|
DNA | 12 | 2016 | 7189 | 0.280 |
Why?
|
Micronuclei, Chromosome-Defective | 1 | 2007 | 38 | 0.280 |
Why?
|
Cell Line | 24 | 2011 | 15545 | 0.280 |
Why?
|
Hippocampus | 1 | 2019 | 3754 | 0.280 |
Why?
|
Histones | 5 | 2024 | 2570 | 0.270 |
Why?
|
Copper | 6 | 1997 | 366 | 0.270 |
Why?
|
Hydroxyl Radical | 6 | 1997 | 82 | 0.270 |
Why?
|
Cell Physiological Phenomena | 2 | 2018 | 149 | 0.270 |
Why?
|
Fanconi Anemia Complementation Group D2 Protein | 3 | 2015 | 146 | 0.270 |
Why?
|
Ultraviolet Rays | 4 | 2019 | 1078 | 0.270 |
Why?
|
Transformation, Bacterial | 4 | 1992 | 76 | 0.260 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 3253 | 0.250 |
Why?
|
DNA, Bacterial | 5 | 1992 | 1470 | 0.240 |
Why?
|
Bacillus subtilis | 5 | 1992 | 351 | 0.240 |
Why?
|
Research | 2 | 2012 | 1976 | 0.240 |
Why?
|
Cricetinae | 15 | 2003 | 2412 | 0.220 |
Why?
|
History, 21st Century | 3 | 2024 | 1567 | 0.220 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3093 | 0.210 |
Why?
|
Cell Communication | 3 | 2012 | 1651 | 0.210 |
Why?
|
Models, Biological | 5 | 2020 | 9458 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3215 | 0.210 |
Why?
|
Cosmic Radiation | 1 | 2022 | 24 | 0.210 |
Why?
|
Humans | 67 | 2024 | 761222 | 0.200 |
Why?
|
Superoxides | 2 | 1994 | 388 | 0.200 |
Why?
|
Nuclear Weapons | 1 | 2021 | 12 | 0.190 |
Why?
|
Peroxides | 3 | 1992 | 74 | 0.190 |
Why?
|
History, 20th Century | 3 | 2024 | 2765 | 0.190 |
Why?
|
Fumarates | 3 | 1993 | 131 | 0.190 |
Why?
|
Neurons | 2 | 2022 | 9429 | 0.190 |
Why?
|
Cell Line, Tumor | 11 | 2024 | 16954 | 0.180 |
Why?
|
Mutagenesis | 3 | 2009 | 1226 | 0.180 |
Why?
|
Animals | 41 | 2024 | 168089 | 0.180 |
Why?
|
Kinetics | 12 | 2013 | 6312 | 0.180 |
Why?
|
Catalase | 4 | 2010 | 217 | 0.170 |
Why?
|
Praseodymium | 1 | 2019 | 1 | 0.170 |
Why?
|
Carbon Radioisotopes | 2 | 2018 | 562 | 0.170 |
Why?
|
Receptor, Parathyroid Hormone, Type 1 | 1 | 2021 | 305 | 0.170 |
Why?
|
Research Design | 1 | 2016 | 6180 | 0.170 |
Why?
|
Osteocytes | 1 | 2021 | 192 | 0.170 |
Why?
|
Immunotherapy | 3 | 2019 | 4642 | 0.170 |
Why?
|
Synapsins | 1 | 2019 | 43 | 0.170 |
Why?
|
Cell Death | 1 | 2005 | 1676 | 0.170 |
Why?
|
Lutetium | 1 | 2019 | 38 | 0.170 |
Why?
|
Risk Assessment | 6 | 2024 | 24022 | 0.170 |
Why?
|
Scattering, Radiation | 2 | 2020 | 490 | 0.160 |
Why?
|
Free Radicals | 6 | 1997 | 238 | 0.160 |
Why?
|
Cell Nucleolus | 1 | 2019 | 153 | 0.160 |
Why?
|
Radiography, Dental | 1 | 2019 | 50 | 0.160 |
Why?
|
Stomatognathic Diseases | 1 | 2019 | 21 | 0.160 |
Why?
|
Coculture Techniques | 3 | 2012 | 1334 | 0.160 |
Why?
|
Deoxyribose | 2 | 1997 | 7 | 0.160 |
Why?
|
X-Ray Therapy | 1 | 2018 | 8 | 0.160 |
Why?
|
Computer Simulation | 4 | 2022 | 6224 | 0.160 |
Why?
|
Cricetulus | 9 | 2003 | 812 | 0.150 |
Why?
|
Gamma Rays | 6 | 2009 | 318 | 0.150 |
Why?
|
Osteoclasts | 1 | 2021 | 711 | 0.150 |
Why?
|
Cells, Cultured | 9 | 2019 | 18927 | 0.140 |
Why?
|
Caspases | 1 | 2000 | 878 | 0.140 |
Why?
|
Reactive Oxygen Species | 5 | 2010 | 2138 | 0.140 |
Why?
|
Nanoparticles | 2 | 2019 | 1959 | 0.140 |
Why?
|
Skin | 1 | 2010 | 4473 | 0.140 |
Why?
|
Neisseria gonorrhoeae | 1 | 2019 | 239 | 0.140 |
Why?
|
Brachytherapy | 1 | 2024 | 1223 | 0.140 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2020 | 549 | 0.140 |
Why?
|
Government Agencies | 1 | 2017 | 160 | 0.130 |
Why?
|
Phantoms, Imaging | 2 | 2020 | 2513 | 0.130 |
Why?
|
Risk | 2 | 2020 | 9616 | 0.130 |
Why?
|
Osteoblasts | 1 | 2021 | 1144 | 0.130 |
Why?
|
Particle Accelerators | 1 | 2017 | 174 | 0.130 |
Why?
|
Macromolecular Substances | 1 | 2018 | 1429 | 0.130 |
Why?
|
Hydroxides | 2 | 1993 | 46 | 0.130 |
Why?
|
Recombinases | 1 | 2016 | 67 | 0.130 |
Why?
|
Chromosome Aberrations | 2 | 2020 | 1767 | 0.130 |
Why?
|
Gonorrhea | 1 | 2019 | 346 | 0.120 |
Why?
|
Parathyroid Hormone | 1 | 2021 | 1803 | 0.120 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2019 | 455 | 0.120 |
Why?
|
Fluoroscopy | 1 | 2019 | 947 | 0.120 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2019 | 2915 | 0.120 |
Why?
|
Fanconi Anemia | 3 | 2016 | 324 | 0.110 |
Why?
|
Neuropeptides | 1 | 2019 | 944 | 0.110 |
Why?
|
Osteosarcoma | 1 | 2019 | 896 | 0.110 |
Why?
|
Ascorbic Acid | 1 | 1997 | 654 | 0.110 |
Why?
|
Chromatography | 2 | 1990 | 188 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor C | 1 | 2013 | 127 | 0.110 |
Why?
|
Endonucleases | 1 | 2016 | 370 | 0.110 |
Why?
|
Pentose Phosphate Pathway | 1 | 1993 | 126 | 0.100 |
Why?
|
Spermidine | 1 | 1992 | 62 | 0.100 |
Why?
|
Congresses as Topic | 1 | 2017 | 803 | 0.100 |
Why?
|
Caffeine | 1 | 1997 | 701 | 0.100 |
Why?
|
Epidemiologic Methods | 1 | 2017 | 1336 | 0.100 |
Why?
|
Adaptation, Physiological | 2 | 2009 | 1301 | 0.100 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2015 | 714 | 0.100 |
Why?
|
Naphthyridines | 1 | 2013 | 143 | 0.100 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2012 | 2871 | 0.100 |
Why?
|
Cations | 1 | 2011 | 238 | 0.090 |
Why?
|
RNA-Binding Proteins | 1 | 2019 | 1855 | 0.090 |
Why?
|
Hydroxyapatites | 1 | 1990 | 73 | 0.090 |
Why?
|
Radiation, Ionizing | 3 | 2019 | 252 | 0.090 |
Why?
|
Phosphoproteins | 1 | 2019 | 2444 | 0.090 |
Why?
|
Polyamines | 1 | 1991 | 133 | 0.090 |
Why?
|
Translocation, Genetic | 1 | 2016 | 1391 | 0.090 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2019 | 1655 | 0.090 |
Why?
|
Cobalt Radioisotopes | 4 | 2016 | 75 | 0.080 |
Why?
|
Deuteroporphyrins | 1 | 2009 | 8 | 0.080 |
Why?
|
Cell Nucleus | 2 | 2020 | 2881 | 0.080 |
Why?
|
Light | 2 | 2019 | 1348 | 0.080 |
Why?
|
Benzimidazoles | 2 | 2013 | 858 | 0.080 |
Why?
|
Combined Modality Therapy | 4 | 2017 | 8519 | 0.080 |
Why?
|
Rats, Inbred F344 | 1 | 2020 | 826 | 0.080 |
Why?
|
Models, Statistical | 2 | 2024 | 5081 | 0.080 |
Why?
|
Radiation Injuries, Experimental | 1 | 1989 | 88 | 0.080 |
Why?
|
Radiology | 1 | 2022 | 2112 | 0.080 |
Why?
|
Quality Assurance, Health Care | 1 | 2019 | 2164 | 0.080 |
Why?
|
Carbon | 1 | 2012 | 665 | 0.080 |
Why?
|
BRCA1 Protein | 1 | 2015 | 1149 | 0.080 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2009 | 123 | 0.080 |
Why?
|
DNA, Single-Stranded | 2 | 1990 | 353 | 0.080 |
Why?
|
Helium | 1 | 2008 | 119 | 0.070 |
Why?
|
HL-60 Cells | 2 | 2000 | 363 | 0.070 |
Why?
|
Organs at Risk | 1 | 2020 | 359 | 0.070 |
Why?
|
Computer Systems | 1 | 2009 | 470 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2020 | 8002 | 0.070 |
Why?
|
Oxidative Stress | 4 | 2019 | 3114 | 0.070 |
Why?
|
Bone Neoplasms | 1 | 2019 | 2527 | 0.070 |
Why?
|
Mitochondria | 1 | 2000 | 3620 | 0.070 |
Why?
|
Oxidation-Reduction | 5 | 2000 | 2227 | 0.070 |
Why?
|
DNA-Binding Proteins | 2 | 2016 | 9567 | 0.070 |
Why?
|
Aerobiosis | 3 | 1996 | 100 | 0.070 |
Why?
|
Catechin | 1 | 2007 | 69 | 0.070 |
Why?
|
Adenosine Triphosphate | 1 | 2013 | 1988 | 0.070 |
Why?
|
Dithioerythritol | 1 | 1986 | 8 | 0.070 |
Why?
|
Carcinoma, Ehrlich Tumor | 1 | 1986 | 23 | 0.070 |
Why?
|
Vitamin E | 2 | 2009 | 872 | 0.070 |
Why?
|
Deoxy Sugars | 1 | 1985 | 20 | 0.060 |
Why?
|
Rats | 5 | 2020 | 23705 | 0.060 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 20588 | 0.060 |
Why?
|
Glomerular Mesangium | 1 | 2005 | 98 | 0.060 |
Why?
|
Acetylcysteine | 2 | 1998 | 260 | 0.060 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2018 | 638 | 0.060 |
Why?
|
Technology, Radiologic | 1 | 2005 | 160 | 0.060 |
Why?
|
Mice | 9 | 2021 | 81330 | 0.060 |
Why?
|
Parents | 1 | 2019 | 3564 | 0.060 |
Why?
|
Photosensitizing Agents | 1 | 2009 | 625 | 0.060 |
Why?
|
Time Factors | 9 | 2010 | 39957 | 0.060 |
Why?
|
Communication | 1 | 2019 | 3872 | 0.060 |
Why?
|
Artificial Intelligence | 1 | 2019 | 2576 | 0.060 |
Why?
|
G1 Phase | 1 | 2005 | 404 | 0.060 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2013 | 2058 | 0.060 |
Why?
|
Tamoxifen | 1 | 2008 | 965 | 0.060 |
Why?
|
Reference Values | 2 | 2015 | 4921 | 0.050 |
Why?
|
History, 19th Century | 1 | 2006 | 718 | 0.050 |
Why?
|
Benchmarking | 1 | 2020 | 1045 | 0.050 |
Why?
|
Histone Acetyltransferases | 1 | 2005 | 335 | 0.050 |
Why?
|
Coumarins | 3 | 1997 | 118 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2019 | 8531 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2013 | 2803 | 0.050 |
Why?
|
Disulfides | 2 | 2000 | 463 | 0.050 |
Why?
|
Fluorescent Dyes | 1 | 2010 | 1901 | 0.050 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6586 | 0.050 |
Why?
|
Multimedia | 1 | 2022 | 75 | 0.050 |
Why?
|
Anaerobiosis | 3 | 1988 | 139 | 0.050 |
Why?
|
Nuclear Power Plants | 1 | 2021 | 13 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 8998 | 0.050 |
Why?
|
Teaching | 1 | 2009 | 1171 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16575 | 0.050 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3446 | 0.050 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2018 | 2509 | 0.050 |
Why?
|
Neutrons | 1 | 2001 | 77 | 0.050 |
Why?
|
Caspase 2 | 1 | 2000 | 26 | 0.050 |
Why?
|
Estradiol | 1 | 2008 | 1937 | 0.050 |
Why?
|
Faculty, Medical | 1 | 2009 | 1205 | 0.050 |
Why?
|
Amino Acid Chloromethyl Ketones | 1 | 2000 | 68 | 0.050 |
Why?
|
Endothelial Cells | 1 | 2013 | 3552 | 0.050 |
Why?
|
Tumor Cells, Cultured | 3 | 2019 | 6125 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8663 | 0.040 |
Why?
|
Free Radical Scavengers | 2 | 1998 | 211 | 0.040 |
Why?
|
Caspase 9 | 1 | 2000 | 184 | 0.040 |
Why?
|
Tumor Microenvironment | 1 | 2013 | 3875 | 0.040 |
Why?
|
DNA Fragmentation | 1 | 2000 | 237 | 0.040 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 2000 | 188 | 0.040 |
Why?
|
Caspase 8 | 1 | 2000 | 190 | 0.040 |
Why?
|
Sodium Azide | 1 | 2019 | 24 | 0.040 |
Why?
|
Lymphocytes | 1 | 2008 | 2603 | 0.040 |
Why?
|
Abetalipoproteinemia | 1 | 2019 | 16 | 0.040 |
Why?
|
Caspase 1 | 1 | 2000 | 226 | 0.040 |
Why?
|
Colorectal Neoplasms | 1 | 2019 | 6919 | 0.040 |
Why?
|
Pyruvic Acid | 1 | 2000 | 203 | 0.040 |
Why?
|
Biology | 1 | 2021 | 290 | 0.040 |
Why?
|
Uncertainty | 1 | 2024 | 752 | 0.040 |
Why?
|
Oxygen Consumption | 1 | 1986 | 1867 | 0.040 |
Why?
|
United States | 5 | 2024 | 72341 | 0.040 |
Why?
|
tert-Butylhydroperoxide | 2 | 1989 | 11 | 0.040 |
Why?
|
RNA, Ribosomal | 1 | 2019 | 223 | 0.040 |
Why?
|
DNA, Ribosomal | 1 | 2019 | 298 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 1993 | 5783 | 0.040 |
Why?
|
CHO Cells | 4 | 2003 | 1379 | 0.040 |
Why?
|
Caspase 3 | 1 | 2000 | 730 | 0.040 |
Why?
|
DNA Glycosylases | 1 | 2019 | 124 | 0.040 |
Why?
|
Bone Diseases, Metabolic | 1 | 2021 | 410 | 0.040 |
Why?
|
Spectrometry, Fluorescence | 2 | 1997 | 683 | 0.040 |
Why?
|
Bone Resorption | 1 | 2021 | 723 | 0.040 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2018 | 375 | 0.040 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2018 | 313 | 0.040 |
Why?
|
Chelating Agents | 2 | 1996 | 383 | 0.040 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 1997 | 45 | 0.040 |
Why?
|
Computer Graphics | 1 | 2019 | 338 | 0.030 |
Why?
|
Bromodeoxyuridine | 1 | 1997 | 310 | 0.030 |
Why?
|
Spectrophotometry | 1 | 1997 | 292 | 0.030 |
Why?
|
Microsatellite Repeats | 1 | 2019 | 782 | 0.030 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 5665 | 0.030 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5321 | 0.030 |
Why?
|
National Cancer Institute (U.S.) | 1 | 2017 | 296 | 0.030 |
Why?
|
Cesium Radioisotopes | 1 | 2016 | 38 | 0.030 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1996 | 206 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2003 | 1662 | 0.030 |
Why?
|
Schools, Medical | 1 | 2022 | 878 | 0.030 |
Why?
|
Chromosomes | 1 | 2019 | 579 | 0.030 |
Why?
|
Research Report | 1 | 2019 | 367 | 0.030 |
Why?
|
Hydrogen-Ion Concentration | 2 | 1997 | 2478 | 0.030 |
Why?
|
Guanosine Triphosphate | 1 | 1996 | 314 | 0.030 |
Why?
|
Buthionine Sulfoximine | 2 | 1998 | 17 | 0.030 |
Why?
|
Carcinoma | 1 | 2007 | 2330 | 0.030 |
Why?
|
Oligopeptides | 1 | 2000 | 1179 | 0.030 |
Why?
|
Cell Cycle | 2 | 2013 | 2926 | 0.030 |
Why?
|
Mercaptoethylamines | 1 | 1994 | 4 | 0.030 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2019 | 585 | 0.030 |
Why?
|
Endodeoxyribonucleases | 1 | 2016 | 164 | 0.030 |
Why?
|
Lung Neoplasms | 3 | 2015 | 13386 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2015 | 13632 | 0.030 |
Why?
|
Penicillamine | 1 | 1994 | 60 | 0.030 |
Why?
|
Photons | 1 | 2018 | 589 | 0.030 |
Why?
|
Cell Proliferation | 3 | 2019 | 10423 | 0.030 |
Why?
|
Vagina | 1 | 2019 | 841 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 1996 | 656 | 0.030 |
Why?
|
Phthalazines | 1 | 2016 | 383 | 0.030 |
Why?
|
Nucleic Acid Conformation | 1 | 2016 | 896 | 0.030 |
Why?
|
Microbial Sensitivity Tests | 1 | 2019 | 1936 | 0.030 |
Why?
|
BRCA2 Protein | 1 | 2017 | 797 | 0.030 |
Why?
|
Protective Agents | 1 | 2013 | 150 | 0.030 |
Why?
|
Microscopy, Fluorescence | 2 | 2010 | 2635 | 0.030 |
Why?
|
Clone Cells | 1 | 1996 | 1668 | 0.030 |
Why?
|
Lymphangiogenesis | 1 | 2013 | 171 | 0.030 |
Why?
|
User-Computer Interface | 1 | 2019 | 1393 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 3 | 1994 | 10756 | 0.020 |
Why?
|
Osteoporosis | 1 | 2021 | 1604 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2017 | 931 | 0.020 |
Why?
|
Metals | 1 | 1996 | 711 | 0.020 |
Why?
|
Plasmids | 1 | 2016 | 2261 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2013 | 1140 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2019 | 36415 | 0.020 |
Why?
|
Bone and Bones | 1 | 2021 | 2568 | 0.020 |
Why?
|
Culture Media | 1 | 1993 | 894 | 0.020 |
Why?
|
Research Personnel | 1 | 2015 | 588 | 0.020 |
Why?
|
Homeostasis | 1 | 2021 | 3322 | 0.020 |
Why?
|
Glutathione Peroxidase | 1 | 1992 | 258 | 0.020 |
Why?
|
Cognition Disorders | 1 | 2024 | 3976 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 1996 | 1743 | 0.020 |
Why?
|
Child | 1 | 2019 | 80154 | 0.020 |
Why?
|
Interferon-gamma | 1 | 2019 | 3155 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2008 | 20982 | 0.020 |
Why?
|
Temperature | 1 | 1997 | 2219 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 2017 | 1052 | 0.020 |
Why?
|
Up-Regulation | 1 | 2019 | 4111 | 0.020 |
Why?
|
Methionine Sulfoximine | 1 | 1989 | 12 | 0.020 |
Why?
|
Glutathione Transferase | 1 | 1992 | 564 | 0.020 |
Why?
|
Onium Compounds | 1 | 2009 | 27 | 0.020 |
Why?
|
Mice, Inbred C3H | 2 | 2007 | 914 | 0.020 |
Why?
|
Teaching Materials | 1 | 2009 | 84 | 0.020 |
Why?
|
Internship and Residency | 1 | 2009 | 5885 | 0.020 |
Why?
|
Curriculum | 1 | 2022 | 3741 | 0.020 |
Why?
|
Drug Synergism | 1 | 2013 | 1756 | 0.020 |
Why?
|
Lung | 3 | 1994 | 9979 | 0.020 |
Why?
|
Biophysics | 1 | 2009 | 379 | 0.020 |
Why?
|
ras Proteins | 1 | 2013 | 1055 | 0.020 |
Why?
|
Practice Guidelines as Topic | 2 | 2019 | 7400 | 0.020 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 11733 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2019 | 3671 | 0.020 |
Why?
|
Tumor Burden | 1 | 2013 | 1892 | 0.020 |
Why?
|
Cysteine | 2 | 1998 | 888 | 0.020 |
Why?
|
Fluorescence | 1 | 2009 | 751 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2018 | 3571 | 0.020 |
Why?
|
Models, Molecular | 1 | 2016 | 5406 | 0.020 |
Why?
|
Culture Media, Conditioned | 1 | 2008 | 522 | 0.020 |
Why?
|
Medicare | 1 | 2024 | 6774 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2021 | 14392 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 1998 | 4513 | 0.020 |
Why?
|
Accreditation | 1 | 2009 | 473 | 0.020 |
Why?
|
Filtration | 1 | 1986 | 228 | 0.020 |
Why?
|
Cytochrome c Group | 1 | 1986 | 122 | 0.020 |
Why?
|
Pulse Radiolysis | 1 | 1985 | 6 | 0.020 |
Why?
|
Ribosemonophosphates | 1 | 1985 | 7 | 0.020 |
Why?
|
Lasers | 1 | 1990 | 952 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5869 | 0.020 |
Why?
|
Transcription, Genetic | 1 | 2019 | 7571 | 0.020 |
Why?
|
Ribose | 1 | 1985 | 63 | 0.020 |
Why?
|
Methods | 1 | 1986 | 1063 | 0.020 |
Why?
|
Group IV Phospholipases A2 | 1 | 2005 | 58 | 0.020 |
Why?
|
Flow Cytometry | 1 | 2016 | 5871 | 0.020 |
Why?
|
Piperazines | 1 | 2016 | 2522 | 0.020 |
Why?
|
Electron Transport | 1 | 1986 | 209 | 0.020 |
Why?
|
Autophagy | 1 | 2013 | 1327 | 0.020 |
Why?
|
Cysteamine | 1 | 1984 | 24 | 0.010 |
Why?
|
Phospholipases A | 1 | 2005 | 204 | 0.010 |
Why?
|
Deoxyglucose | 1 | 1985 | 333 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2019 | 3534 | 0.010 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3593 | 0.010 |
Why?
|
Recombination, Genetic | 1 | 2009 | 1518 | 0.010 |
Why?
|
Demography | 1 | 2009 | 1641 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2013 | 2455 | 0.010 |
Why?
|
Mentors | 1 | 2009 | 663 | 0.010 |
Why?
|
Ovary | 1 | 1988 | 957 | 0.010 |
Why?
|
Canada | 1 | 2009 | 2125 | 0.010 |
Why?
|
Female | 6 | 2024 | 392552 | 0.010 |
Why?
|
Male | 3 | 2024 | 360703 | 0.010 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2813 | 0.010 |
Why?
|
COS Cells | 1 | 2005 | 1129 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2019 | 9417 | 0.010 |
Why?
|
Electrons | 1 | 1984 | 265 | 0.010 |
Why?
|
Photochemotherapy | 1 | 2009 | 826 | 0.010 |
Why?
|
Ethanol | 2 | 1979 | 1322 | 0.010 |
Why?
|
Educational Measurement | 1 | 2009 | 1250 | 0.010 |
Why?
|
Drug Interactions | 1 | 1986 | 1417 | 0.010 |
Why?
|
Educational Status | 1 | 2009 | 2510 | 0.010 |
Why?
|
Mutation | 2 | 2019 | 30004 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 7407 | 0.010 |
Why?
|
Dithionitrobenzoic Acid | 1 | 2000 | 20 | 0.010 |
Why?
|
Diamide | 1 | 2000 | 17 | 0.010 |
Why?
|
Selenium Compounds | 1 | 2000 | 11 | 0.010 |
Why?
|
Protein Binding | 1 | 2013 | 9297 | 0.010 |
Why?
|
Carmustine | 1 | 2000 | 137 | 0.010 |
Why?
|
Thioctic Acid | 1 | 2000 | 28 | 0.010 |
Why?
|
Forecasting | 1 | 2009 | 2928 | 0.010 |
Why?
|
Arsenites | 1 | 2000 | 65 | 0.010 |
Why?
|
Cystine | 1 | 2000 | 93 | 0.010 |
Why?
|
Arsenicals | 1 | 2000 | 117 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-fyn | 1 | 1998 | 110 | 0.010 |
Why?
|
Escherichia coli | 1 | 1991 | 4201 | 0.010 |
Why?
|
Chromatin | 1 | 2010 | 2946 | 0.010 |
Why?
|
Butanols | 1 | 1978 | 19 | 0.010 |
Why?
|
Hydroxylation | 1 | 1997 | 137 | 0.010 |
Why?
|
Nitrous Oxide | 1 | 1978 | 166 | 0.010 |
Why?
|
Transfection | 1 | 2005 | 5748 | 0.010 |
Why?
|
Societies, Medical | 1 | 2009 | 3923 | 0.010 |
Why?
|
Nitrogen | 1 | 1978 | 345 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2007 | 2636 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15521 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1997 | 1535 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2007 | 3410 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2013 | 18222 | 0.010 |
Why?
|
Pilot Projects | 1 | 2007 | 8642 | 0.010 |
Why?
|
Molecular Structure | 1 | 1997 | 1875 | 0.010 |
Why?
|
Age Factors | 1 | 2009 | 18384 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2005 | 11067 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2009 | 20118 | 0.010 |
Why?
|
Bacteria | 1 | 1981 | 2190 | 0.010 |
Why?
|
Tetrazolium Salts | 1 | 1990 | 92 | 0.010 |
Why?
|
Aging | 1 | 2009 | 8702 | 0.010 |
Why?
|
Arachidonic Acids | 1 | 1990 | 294 | 0.010 |
Why?
|
Phosphorylation | 1 | 1998 | 8300 | 0.000 |
Why?
|
Thiazoles | 1 | 1990 | 1517 | 0.000 |
Why?
|
Cell Membrane | 1 | 1990 | 3661 | 0.000 |
Why?
|
Adult | 1 | 2013 | 221120 | 0.000 |
Why?
|
Middle Aged | 1 | 2009 | 220858 | 0.000 |
Why?
|